ZDA
MDCO

Zweig-DiMenna Associates’s Medicines Co MDCO Stock Holding History

Zweig-DiMenna Associates’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-52,350
Closed -$1.96M – 294
2015
Q4 		$1.96M Sell
52,350
-172,900
-77% -$6.53M 0.1% 129
2015
Q3 		$8.55M Buy
+225,250
New +$7.91M 0.37% 80
2014
Q2 		– Sell
-293,500
Closed -$8.34M – 311
2014
Q1 		$8.34M Buy
+293,500
New +$9.71M 0.49% 72
2013
Q4 		– Sell
-645,000
Closed -$21.6M – 321
2013
Q3 		$21.6M Buy
+645,000
New +$20.5M 0.88% 41

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Zweig-DiMenna Associates's MDCO Position: Q1 2016 in Review

Zweig-DiMenna Associates sold out of Medicines Co (MDCO) in Q1 2016, closing a stake of 52,350 shares — an estimated $1.96M sold.

Zweig-DiMenna Associates first reported a position in MDCO in Q3 2013 and held it in 4 quarters. The position peaked at $21.6M in Q3 2013. 181 funds tracked by Wall St. Rank hold MDCO as of Q1 2016.

  • Zweig-DiMenna Associates reported no remaining Medicines Co position as of Q1 2016 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 52,350 Medicines Co shares in Q1 2016, an estimated $1.96M.
  • Zweig-DiMenna Associates first reported a position in Medicines Co in Q3 2013 and held it in 4 quarters.
  • Zweig-DiMenna Associates's Medicines Co position peaked at $21.6M in Q3 2013.
  • 181 funds tracked by Wall St. Rank held Medicines Co as of Q1 2016.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2016, filed 10 May 2016.